State Councilor and Foreign Minister Wang Yi said on Friday that with joint efforts of China and Hungary, vaccine cooperation will definitely become an upgraded version of anti-COVID-19 cooperation between the two countries.
CHINA approved its first homegrown COVID-19 vaccine for general public use yesterday, and vowed to provide free vaccines to all its citizens, marking a major stride toward inoculating the world’s largest
Chinese vaccine proves 79.34 pct effective against COVID-19 in phase-3 study Xinhua | Updated: 2020-12-30 17:59 Share CLOSE A coronavirus disease (COVID-19) Human Immunoglobulin for Intravenous Injection from China National Biotec Group (CNBG). [Photo/Agencies]
BEIJING - A Chinese inactivated vaccine shows 79.34 percent efficacy against COVID-19, according to the interim results of the phase-3 clinical trials unveiled by its developer Wednesday.
The inactivated vaccine is developed by the Beijing Biological Products Institute Co Ltd under the China National Biotec Group, which is affiliated with Sinopharm.
After a two-dose inoculation procedure, the vaccine receivers all produced high titers of antibodies, and the seroconversion rate of neutralizing antibodies reached 99.52 percent.